Guardant Health revenue and financials
$170.69Change from previous close: −8.83%Absolute change: −$16.53
In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +32.88%
- 2025 vs 2024
- Net margin
- -42.4%
- 2024: -59.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 335 | 302 | 281 | 265 | 232 | 203 | 202 | 191 | 177 | 168 | 155 | 143 |
| Cost of revenue | 116 | 105 | 99.5 | 93.6 | 81.2 | 74.7 | 77.6 | 74.5 | 72.4 | 65.3 | 62.5 | 57.6 |
| Gross profit | 219 | 197 | 182 | 172 | 151 | 129 | 124 | 117 | 105 | 103 | 92.5 | 85.4 |
| Selling, general and administrative | 251 | 227 | 204 | 181 | 170 | 151 | 156 | 147 | 122 | 119 | 117 | 105 |
| Research and development | 96.5 | 91.0 | 98.3 | 90.0 | 87.4 | 88.5 | 93.5 | 87.3 | 83.1 | 83.8 | 89.9 | 93.9 |
| Operating income | -128 | -121 | -121 | -98.9 | -106 | -111 | -126 | -117 | -100 | -99.6 | -114 | -113 |
| EBIT | -128 | -121 | -121 | -98.9 | -106 | -111 | -126 | -117 | -100 | -99.6 | -114 | -113 |
| EBITDA | -119 | -112 | -111 | -89.5 | -96.1 | -100 | -115 | -106 | -89.7 | -88.9 | -103 | -102 |
| Interest expense | 1.3 | 3.1 | 1.2 | 0.9 | 1.0 | 1.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| Pre-tax income | -120 | -112 | -130 | -92.6 | -99.9 | -94.9 | -110 | -108 | -102 | -115 | -188 | -85.6 |
| Income tax | 0.2 | 0.4 | -1.7 | 0.1 | 0.0 | 0.3 | 0.7 | 0.0 | 0.1 | 0.4 | -0.5 | 0.5 |
| Net income | -120 | -112 | -128 | -92.7 | -99.9 | -95.2 | -111 | -108 | -103 | -115 | -187 | -86.1 |
| Net income to common shareholders | -120 | -112 | -128 | -92.7 | -99.9 | -95.2 | -111 | -108 | -103 | -115 | -187 | -86.1 |
| Basic EPS | -0.90 | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 | -1.58 | -0.73 |
| Diluted EPS | -0.90 | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 | -1.58 | -0.73 |
| Average shares (basic) | 133 | 131 | 129 | 125 | 124 | 124 | 124 | 123 | 122 | 122 | 119 | 118 |
| Average shares (diluted) | 133 | 131 | 129 | 125 | 124 | 124 | 124 | 123 | 122 | 122 | 119 | 118 |